COLO B Coloplast A/S Class B

Coloplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22

Coloplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22

Coloplast is a purpose-driven company: We make life easier for people living with intimate healthcare needs. In 2021/22, we continued to help more than two million users globally, but many user needs remain unmet across our business areas. We strive to build better standards of care, raise the bar with innovative products and create access for as many users as possible. We are building the consumer healthcare company of the future – enabling self-care for chronic users and supporting healthcare systems to meet, in a cost-effective way, increasing demand as the world population ages. This is a direct embodiment of the Coloplast mission and our key contribution to sustainable development.

As part of our corporate strategy, Strive25, we have made it a clear priority to grow our business in a sustainable way. We focus on improving our products and packaging and reducing our emissions while always operating responsibly. To deliver on our 2025 ambitions, we are investing up to DKK 250 million during the strategy period.

During FY 2021/22, Coloplast made progress on key ambitions, including welcoming 250,000 new patients into the Coloplast® Care programme, increasing the recycling rate of production waste to 71% (up from 58% in 2020/21) and reducing our scope 1 and 2 emissions by 8% since the base year 2018/19.

Please find our Sustainability Report 2021/22 on the link below.

Our mission

Making life easier for people

with intimate health care needs



Our values

Closeness... to better understand

Passion... to make a difference

Respect and responsibility... to guide us



Our vision

Setting the global standard

for listening and responding

  

For further information, please contact

Investors and analysts

Anders Lonning-Skovgaard

Executive Vice President, CFO

Tel.

Aleksandra Dimovska

Director, Investor Relations

Tel. /

Email:

Kristine Husted Munk

Senior Manager, Investor Relations

Tel. /

Email:

Press and media

Peter Mønster

Sr. Media Relations Manager

Tel.

Email:  

Address

Coloplast A/S

Holtedam 1

DK-3050 Humlebaek

Denmark

Company reg. (CVR) no. 69749917

Website

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice and Respiratory Care. We operate globally and employ more than 14,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-11.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment



EN
07/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 Sep...

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.The purpose of the event is to give institutional investors and financial analysts an introductio...

Coloplast AS: 1 director

A director at Coloplast AS bought 18,450 shares at 650.500DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch